DYNE THERAPEUTICS INC shareholders Q3 2023

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lindbrook Capital, LLC 136$1,2190.00%
Citadel Advisors 6,100$54,6560.00%
Citadel Advisors 5,800$51,9680.00%
PRINCIPAL FINANCIAL GROUP INC 15,229$136,4520.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 74,048$663,4700.00%
UBS Group AG 54,158$485,2560.00%
SIGNATUREFD, LLC 111$9950.00%
Swiss National Bank 63,500$568,9600.00%
JANE STREET GROUP, LLC 51,221$458,9400.00%
BANK OF AMERICA CORP /DE/ 93,761$840,0990.00%
US BANCORP \DE\ 61$5470.00%
Daiwa Securities Group Inc. 210$20.00%
WELLS FARGO & COMPANY/MN 35,246$315,8040.00%
Washington Trust Advisors, Inc. 125$1,1200.00%
AMERICAN CENTURY COMPANIES INC 27,407$245,5670.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 25,129$225,1560.00%
TD ASSET MANAGEMENT INC 23,000$206,0800.00%
Legal & General Group Plc 24,092$215,8650.00%
SIMPLEX TRADING, LLC 36,032$3220.00%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2023. To view DYNE THERAPEUTICS INC's shareholder history, click here.